SETDB2 induces abnormal SHP-1 splicing and promotes immunosuppression in hepatocellular carcinoma. Jiao Q, Ren Y, Su X, Li Z, et al. Oncogene 2026 Apr 7. doi: 10.1038/s41388-026-03759.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiao Q, Ren Y, Su X, Li Z, et al. SETDB2 induces abnormal SHP-1 splicing and promotes immunosuppression in hepatocellular carcinoma. Oncogene 2026 Apr 7. doi: 10.1038/s41388-026-03759.
PMID: 41946995